HSDT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Helius Medical Technologies Insider Trading History Chart

Helius Medical Technologies Share Price & Price History

^$0.91

▲ +0.43 (89.58%)

As of 12/20/2024 06:45 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Helius Medical Technologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/14/2023	Dane C. Andreeff	CEO	Buy	5,000	$8.10	$40,500.00	16,512
11/30/2023	Dane C. Andreeff	CEO	Buy	2,000	$6.37	$12,740.00	12,551
8/30/2023	Dane C. Andreeff	CEO	Buy	5,000	$7.64	$38,200.00	11,420
8/28/2023	Dane C. Andreeff	CEO	Buy	5,078	$6.37	$32,346.86	8,774
12/16/2022	Dane C. Andreeff	CEO	Buy	1,600	$12.50	$20,000.00	6,650
11/22/2022	Dane C. Andreeff	CEO	Buy	200	$14.00	$2,800.00	4,371
9/12/2022	Dane C. Andreeff	CEO	Buy	177	$27.00	$4,779.00	2,896
8/24/2022	Dane C. Andreeff	CEO	Buy	504	$32.50	$16,380.00	1,999

Rare "crisis signal" triggers for third time in U.S. market

From Stansberry Research | Ad

A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years.

Click here for all the details.

SEC Filings (Institutional Ownership Changes) for Helius Medical Technologies (NASDAQ:HSDT)

18.63% of Helius Medical Technologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Helius Medical Technologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	Armistice Capital LLC	130,000	$0.13M	0.0%	N/A	4.387%
7/20/2022	Delta Investment Management LLC	26,784	$32K	0.0%	-31.8%	0.705%
2/15/2022	Kepos Capital LP	100,304	$0.52M	0.0%	+296.4%	4.190%
2/14/2022	Altium Capital Management LP	48,862	$0.25M	0.1%	N/A	2.041%
2/11/2022	Rovida Advisors Inc.	26,934	$0.14M	0.0%	-27.1%	1.125%
2/10/2022	AIGH Capital Management LLC	250,000	$1.30M	0.4%	N/A	10.443%
2/3/2022	ACT Capital Management LLC	35,263	$0.18M	0.1%	-50.1%	1.473%
11/16/2021	ACT Capital L.L.C.	70,616	$1.02M	0.5%	+19.3%	2.950%
11/12/2021	Renaissance Technologies LLC	37,270	$0.54M	0.0%	-9.0%	1.604%
11/12/2021	Delta Investment Management LLC	37,184	$0.54M	0.2%	N/A	1.601%
8/17/2021	Worth Venture Partners LLC	17,915	$0.30M	0.1%	-24.7%	0.771%
8/13/2021	Renaissance Technologies LLC	40,970	$0.70M	0.0%	-8.1%	1.764%
8/13/2021	Geode Capital Management LLC	16,390	$0.28M	0.0%	+57.2%	0.706%
8/13/2021	Vanguard Group Inc.	78,898	$1.34M	0.0%	+186.4%	3.396%
8/10/2021	Isthmus Partners LLC	5,595	$95K	0.0%	N/A	0.241%
5/19/2021	Worth Venture Partners LLC	23,785	$0.43M	0.2%	N/A	1.027%
5/14/2021	Rovida Advisors Inc.	36,934	$0.65M	0.0%	-97.1%	1.594%
5/13/2021	Renaissance Technologies LLC	44,570	$0.80M	0.0%	-96.1%	1.924%
5/13/2021	Kepos Capital LP	25,304	$0.46M	0.0%	N/A	1.092%
5/12/2021	Geode Capital Management LLC	10,426	$0.19M	0.0%	N/A	0.450%
5/12/2021	UBS Group AG	2,305	$41K	0.0%	+1,180.6%	0.099%
5/7/2021	BlackRock Inc.	3,041	$55K	0.0%	-97.1%	0.131%
3/25/2021	Rollins Financial	100,000	$38K	0.0%	N/A	4.327%
2/16/2021	Isthmus Partners LLC	195,829	$74K	0.0%	-4.4%	8.474%
2/10/2021	Renaissance Technologies LLC	1,139,288	$0.43M	0.0%	+9.2%	76.771%
2/5/2021	BlackRock Inc.	106,546	$41K	0.0%	+2.2%	7.103%

Data available starting January 2016

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Today's Range

Now: $0.91

$0.70

$1.45

50 Day Range

MA: $0.53

$0.38

$0.91

52 Week Range

Now: $0.91

$0.37

$9.50

Volume

121,971,336 shs

Average Volume

839,833 shs

Market Capitalization

$3.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Who are the company insiders with the largest holdings of Helius Medical Technologies?: Helius Medical Technologies' top insider shareholders include:
Dane Andreeff (CEO)
Learn More about top insider investors at Helius Medical Technologies.